Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...141142143144145146147148149150...
CompanyDrug NameStatusIndication Group
Dynport Vaccine No drug name Approved in USAAnti-infectives for systemic use
Acambis No drug name in Phase IIAnti-infectives for systemic use
VaxGen No drug name in Phase IIAnti-infectives for systemic use
Acambis No drug name Submitted for approval in USAAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IINervous system
Sanofi-aventis No drug name accomplished Phase IINervous system
Bristol-Myers Squibb No drug name in Phase IIIAntineoplastic & immunomodulating agents
Vion No drug name in Phase IIAntineoplastic & immunomodulating agents
Solvay No drug name Approved in JapanNervous system
Abbott Laboratories No drug name in Phase IIAntineoplastic & immunomodulating agents
AETERNA ZENTARIS No drug name accomplished Phase IIAntineoplastic & immunomodulating agents
CuraGen No drug name in Phase IIAntineoplastic & immunomodulating agents
Acusphere No drug name accomplished Phase IAntineoplastic & immunomodulating agents
Adherex Technologies No drug name in Phase IAntineoplastic & immunomodulating agents
ArQule No drug name in Phase IIAntineoplastic & immunomodulating agents
AstraZeneca No drug name discontinuedAntineoplastic & immunomodulating agents
AstraZeneca No drug name discontinuedAntineoplastic & immunomodulating agents
Threshold No drug name in Phase IAntineoplastic & immunomodulating agents
Wilex AG No drug name in Phase IAntineoplastic & immunomodulating agents
Can-Fite Biopharma No drug name in Phase IAntineoplastic & immunomodulating agents
...141142143144145146147148149150...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.